AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
2
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
3
Boomi acquires Israeli data management startup Rivery in $100M deal
4
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
5
Decart raises $32M in second funding round in two months, aims to rival OpenAI and Anthropic
More news

FSD Pharma

3 stories about FSD Pharma
ד"ר ראזה בוקארי יו"ר משותף ומנכ"ל FSD פארמה

FSD Pharma’s Acquisition of Therapix Hits a Snag

12.12.18|Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
ד"ר ראזה בוקארי יו"ר משותף ומנכ"ל FSD פארמה

FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed

28.11.18|Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases